Lung Cancers Completed Phase 1 Trials for Amrubicin (DB06263)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00890955Amrubicin + Cyclophosphamide in Advanced Solid Organ MalignanciesTreatment
NCT00132054Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung CancerTreatment